Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Veracyte, Inc. - Common Stock
(NQ:
VCYT
)
48.55
+0.35 (+0.73%)
Delayed Quote
Updated: 10:31 AM EDT, Oct 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Veracyte, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Why Veracyte Stock Is Skyrocketing Higher This Week
↗
May 08, 2026
Veracyte's first-quarter earnings were excellent, and the company's future looks bright.
Via
The Motley Fool
Veracyte Inc (NASDAQ:VCYT) Smashes Q1 Estimates and Raises Full-Year Guidance, Shares Surge
↗
May 05, 2026
Via
Chartmill
Veracyte (VCYT) Q1 2026 Earnings Transcript
↗
May 05, 2026
Veracyte (VCYT) Q1 2026 Earnings Transcript
Via
The Motley Fool
Get insights into the top gainers and losers of Tuesday's after-hours session.
↗
May 05, 2026
Via
Chartmill
Veracyte Inc (NASDAQ:VCYT) GARP Analysis Reveals Strong Growth at a Reasonable Price
↗
May 02, 2026
Via
Chartmill
Veracyte Inc (NASDAQ:VCYT): A High-Growth Biotech Stock Poised for a Technical Breakout
↗
April 29, 2026
Via
Chartmill
Veracyte Inc (NASDAQ:VCYT) Emerges as a Prime Growth at a Reasonable Price (GARP) Candidate
↗
April 02, 2026
Via
Chartmill
Veracyte Inc (NASDAQ:VCYT) Posts Strong Q4 Earnings Beat and Positive 2026 Outlook
↗
February 25, 2026
Via
Chartmill
Topics
Earnings
Veracyte Announces First Quarter 2026 Financial Results
May 05, 2026
From
Veracyte, Inc.
Via
Business Wire
Veracyte Announces New Data at AUA 2026 Highlighting the Power of the Decipher Portfolio to Advance Personalized Care in Urologic Cancers
April 28, 2026
From
Veracyte, Inc.
Via
Business Wire
Curious about the stocks that are showing activity after the closing bell on Thursday?
↗
April 16, 2026
Via
Chartmill
Veracyte to Release First Quarter 2026 Financial Results on May 5, 2026
April 14, 2026
From
Veracyte, Inc.
Via
Business Wire
Veracyte Inc (NASDAQ:VCYT): A Prime GARP Stock with Strong Growth and a Sound Balance Sheet
↗
February 21, 2026
Via
Chartmill
Veracyte Inc. (NASDAQ:VCYT) Emerges as a Prime Affordable Growth Candidate
↗
January 26, 2026
Via
Chartmill
Veracyte Names Kevin Haas as Chief Development and Technology Officer
March 16, 2026
From
Veracyte, Inc.
Via
Business Wire
Veracyte (VCYT) Q4 2025 Earnings Call Transcript
↗
February 25, 2026
Veracyte (VCYT) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Veracyte Announces Fourth Quarter and Full Year 2025 Financial Results
February 25, 2026
From
Veracyte, Inc.
Via
Business Wire
Veracyte to Highlight Extensive Decipher® Data at 2026 ASCO GU Symposium
February 24, 2026
From
Veracyte
Via
Business Wire
Earnings Scheduled For November 4, 2025
↗
November 04, 2025
Via
Benzinga
Veracyte to Participate in Upcoming Investor Conferences
February 19, 2026
From
Veracyte, Inc.
Via
Business Wire
Veracyte to Release Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026
February 04, 2026
From
Veracyte, Inc.
Via
Business Wire
Biodesix Shares Rocket 42% on Record FY2025 Results and Path to Profitability
January 12, 2026
On January 12, 2026, the diagnostic sector witnessed a seismic shift as shares of Biodesix (Nasdaq: BDSX) surged more than 40% in early trading, following the release of preliminary full-year 2025...
Via
MarketMinute
Topics
Artificial Intelligence
Death
Veracyte Announces Preliminary Fourth Quarter and Full-Year 2025 Results
January 11, 2026
From
Veracyte, Inc.
Via
Business Wire
Veracyte to Participate in the 44th Annual J.P. Morgan Healthcare Conference
December 29, 2025
From
Veracyte, Inc.
Via
Business Wire
Veracyte Inc (NASDAQ:VCYT) Emerges as a Top Affordable Growth Stock
↗
December 25, 2025
Veracyte (VCYT) exemplifies the GARP strategy, offering strong growth, a reasonable industry price, and a solid debt-free financial foundation.
Via
Chartmill
Veracyte Inc (NASDAQ:VCYT): A GARP Stock With Strong Growth and a Reasonable Price
↗
December 02, 2025
Veracyte (VCYT) exemplifies GARP investing with strong cancer diagnostic growth, reasonable valuation vs. biotech peers, and a debt-free financial foundation.
Via
Chartmill
Veracyte to Participate in Upcoming Investor Conferences
November 06, 2025
From
Veracyte, Inc.
Via
Business Wire
Johnson Controls, Babcock & Wilcox, Lemonade, Lumentum, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday
↗
November 05, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
November 05, 2025
Via
Benzinga
Veracyte Announces Third Quarter 2025 Financial Results
November 04, 2025
From
Veracyte, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
